The human ehrlichioses in the United States

Emerging Infectious Diseases

Volumn 5, Issue 5, 1999, Pages 635-642

  McQuiston, Jennifer H ^a   Paddock, Christopher D ^a   Holman, Robert C ^a   Childs, James E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA;

ARTICLE; EHRLICHIA; EHRLICHIOSIS; HEALTH SURVEY; HUMAN; IMMUNOFLUORESCENCE; POLYMERASE CHAIN REACTION; PUBLIC HEALTH; SERODIAGNOSIS; TICK BORNE DISEASE; UNITED STATES; ZOONOSIS;

EID: 0032747711     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0505.990504     Document Type: Article

References (29)

1. Anderson BE, Dawson JE, Jones DC, Wilson KH. Ehrlichia chaffeensis, a new species associated with human ehrlichiosis. J Clin Microbiol 1991;29:2838-42.
2. Chen S, Dumler JS, Bakken JS, Walker DH. Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease. J Clin Microbiol 1994;32:589-95.
3. Hmiel SP, Buller R, Arens M, Gaudreault-Keener M, Storch GA. Human infection with Ehrlichia ewingii, the agent of Ozark canine granulocytic ehrlichiosis. Proceedings of the First International Conference on Emerging Infectious Diseases; 1998 Mar 8-11; Atlanta, Georgia; Addendum:4. [Abstract].
4. Bakken JS, Krueth J, Wilson-Nordskog C, Tilden RL, Asanovich K, Dumler JS. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA 1996;275:199-205.
5. Dawson JE, Warner CK, Standaert S, Olson JG. The interface between research and the diagnosis of an emerging tick-borne disease, human ehrlichiosis due to Ehrlichia chaffeensis. Arch Intern Med 1996;156:137-42.
6. Eng TR, Harkess JR, Fishbein DB, Dawson JE, Greene CN, Redus MA, et al. Epidemiologic, clinical, and laboratory findings of human ehrlichiosis in the United States, 1988. JAMA 1990;264:2251-8.
7. Fishbein DB, Dawson JE, Robinson LE. Human ehrlichiosis in the United States, 1985 to 1990. Ann Intern Med 1994;120:736-43.
8. Fritz CL, Glaser CA. Ehrlichiosis. Infect Dis Clin North Am 1998;12:123-36.
9. Aguero-Rosenfeld ME, Horowitz HW, Wormser GP, McKenna DF, Nowakowski J, Munoz J, et al. Human granulocytic ehrlichiosis: a case series from a medical center in New York state. Ann Intern Med 1996;125:904-8.
10. Dumler JS, Bakken JS. Ehrlichial diseases of humans: emerging tick-borne infections. Clin Infect Dis 1995;20:1102-10.
11. Centers for Diseases Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWRMorb Mortal Wkly Rep 1997;46 46-7.
12. Arguin PM, Singleton J, Rotz LD, Marston E, Treadwell TA, Slater K, et al. An investigation into the possibility of transmission of tick-borne pathogens via blood transfusion. Transfusion. In press 1999.
13. Horowitz HW, Kilchevsky E, Haber S, Aguero-Rosenfeld M, Kranwinkel R, James EK, et al. Perinatal transmission of the agent of human granulocytic ehrlichiosis. N Engl J Med 1998;339:375-8.
14. Belongia E, Reed K, Mitchell P, Chyou P, Persing D, Finkel M, et al. Active surveillance for human granulocytic ehrlichiosis (HGE) in Northwestern Wisconsin: first year results. Proceedings of the First International Conference on Emerging Infectious Diseases; 1998 Mar 8-11; Atlanta, Georgia; p. 106 [abstract].
15. Hardin LE, Satalowich FT. Tick-borne disease summary - 1997. Missouri Epidemiologist; 1998. p. 6-9.
16. Rawlings J. Human ehrlichiosis in Texas. Journal of Spirochetal and Tick-Borne Diseases 1996;3:94-7.
17. Satalowich FT. Tick-borne disease summary - 1996. Missouri Epidemiologist; 1997. p. 10-2.
18. Bureau of Census. Intercensual estimates of the population of counties by age, sex, and race: 1995. Washington: The Bureau; 1996.
19. Anderson BE, Sims KG, Olson JG, Childs JE, Piesman JR, Happ CM, et al. Amblyomma americanum: a potential vector of human ehrlichiosis. Am J Trop Med Hyg 1993;49:239-44.
20. Magnarelli LA, Stafford KC, Mather TN, Yeh M, Horn KD, Dumler JS. Hemocytic rickettsia-like organisms in ticks: serologic reactivity with antisera to Ehrlichiae and detection of DNA of the agent of human granulocytic ehrlichiosis by PCR. J Clin Microbiol 1995,33:2710-4.
21. Pancholi P, Kolbert CP, Mitchell PD, Reed KD, Dumler JS, Bakken JS, et al. Ixodes dammini as a potential vector of human granulocytic ehrlichiosis. J Infect Dis 1995;172:1007-12.
22. Richter PJ Jr, Kimsey RB, Madigan JE, Barlough JE, Dumler JS, Brooks DL. Ixodes pacificus (Acari: Ixodidae) as a vector of Ehrlichia equi (Rickettsiales: Ehrlichieae). J Med Entomol 1996;33:1-5.
23. Dawson JE, Rikihisa Y, Ewing SA, Fishbein DB. Serologic diagnosis of human ehrlichiosis using two Ehrlichia canis isolates. J Infect Dis 1991;163:564-7.
24. Nicholson WL, Comer JA, Sumner JW, Gingrich-Baker C, Coughlin RT, Magnarelli LA, et al. An indirect immunofluorescence assay using a cell culture-derived antigen for detection of antibodies to the agent of human granulocytic ehrlichiosis. J Clin Microbiol 1997;35:1510-6.
25. Comer JA, Nicholson WL, Olson JG, Childs JE. Serologic testing for human granulocytic ehrlichiosis at a national referral center. J Clin Microbiol 1999;37:558-64.
26. Centers for Disease Control and Prevention. Human ehrlichiosis - Maryland, 1994. MMWR Morb Mortal Wkly Rep 1996;45:798-802.
27. Centers for Disease Control and Prevention. Human granulocytic ehrlichiosis - New York, 1995. MMWR Morb Mortal Wkly Rep 1995;44:593-5.
28. Centers for Disease Control and Prevention. Statewide surveillance for ehrlichiosis - Connecticut and New York, 1994-1997. MMWR Morb Mortal Wkly Rep 1998;47:476-80.
29. Dalton MJ, Clarke MJ, Holman RC, Krebs JW, Fishbein DB, Olson JG, et al. National surveillance for Rocky Mountain spotted fever, 1981-1992: epidemiologic summary and evaluation of risk factors for fatal outcome. Am J Trop Med Hyg 1995;52:405-13.